🇺🇸 FDA
Pipeline program

PH-10

PH-10-AD-21

Phase 2 small_molecule completed

Quick answer

PH-10 for Atopic Dermatitis is a Phase 2 program (small_molecule) at PROVECTUS BIOPHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
PROVECTUS BIOPHARMACEUTICALS, INC.
Indication
Atopic Dermatitis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials